CEACAM5 and gastric cancer: While many biomarkers for GC have been reported, such as carbohydrate antigen (CA) 72-4, alpha-fetoprotein, and CA12-5, carcinoembryonic antigen and CA19-9 are still the most frequently used biomarkers for GC in clinical practice [6,7].